Free Republic

Mylan (NASDAQ:MYL) has restarted production of its hydroxychloroquine sulfate tablets at its West Virginia manufacturing facility as a potential treatment for COVID-19, the disease caused by the new coronavirus. The company plans to have product available by mid-April and thinks it can ramp up to 50 million tablets, which could treat more than 1.5 million people. Chloroquine and hydroxychloroquine, a less toxic metabolite of chloroquine, are antiviral medications that are approved to treat malaria. Because it's less toxic and has anti-inflammatory properties, hydroxychloroquine is also approved to treat a pair of auto-immune disorders, lupus erythematosus and rheumatoid arthritis. An article...

Mylan’s EpiPen Pretax Profits 60% Higher Than Number Told to CongressCompany applied 37.5% tax rate onto the profits it revealed to a House committee hearing last weekMylan CEO Heather Bresch takes her seat on Capitol Hill in Washington on Wednesday prior to testifying before the House Oversight Committee hearing on EpiPen price increases. Photo: Pablo Martinez Monsivais/Associated Press "> Mylan NV on Monday clarified the profit it said it made from its lifesaving EpiPen drug, days after House members badgered the company’s chief executive to justify the device’s steep price increases. Testifying before a congressional committee last week, CEO...

CHARLESTON, W.Va. — The highly anticipated trip to Capitol Hill for Mylan CEO Heather Bresch, a Marion County native and daughter of U.S. Senator Joe Manchin (D-W.Va.) who has been under fire for rapid hikes in EpiPen prices, comes this week. Bresch, who lead Mylan’s lobbying efforts to expand the usage of EpiPens which can reverse potentially fatal allergic reactions, was scheduled to testify in front of the U.S. House Committee on Oversight and Government Reform on Wednesday. Prices of EpiPens have climbed by more than 400 percent since 2007 to upwards of $600 for a two-pack. On Tuesday, the...

Mylan to Launch a Lower Cost Generic EpiPenUpdated Sept. 1: Mylan announced on Aug. 29 that it will launch a generic version of its EpiPen at half the cost of the patented original. It plans to introduce a generic two-pack of auto-injectors for $300, compared to the list price of $609 on the branded auto-injector set. Facing relentless pressure from politicians, the media and social media over steep increases on EpiPens, this was the second move Mylan has made on auto-injector pricing in less than a week. Given that the EpiPen brand still has patent protection, the generic announcement...

Sarah Jessica Parker has stepped down as the face of pharma company Mylan after it emerged the company had raised the price of its life-saving EpiPens by 548 per cent. In a post on Instagram Thursday, the 'Sex and the City' actress said she was 'disappointed, saddened and deeply concerned' and called for Mylan to reverse the price hike. Her announcement came the same day that the beleaguered company - which has faced an outpouring of scorn since the price increase came to light - was challenged by Senator Joe Manchin, father of Mylan CEO Heather Bresch.

Hillary feigns outrage, but everything about this has Democrat fingerprints on it Just like earlier this year with Martin Shkreli and Daraprim, the Internet is full of outrage the past few days over the action of Mylan CEO Heather Fausch to raise the price of the live-saving drug EpiPen to $500 per unit. And as always happens, politicians are getting into the act, particularly Hillary Clinton, who raged that Mylan must reduce the price immediately - as if pharmaceutical companies check with candidates for political office in setting their pricing. But if Hillary really wants to manifest her rage -...

A couple of years ago, I got my front teeth knocked out by a combination of bad decisions and gravity. I had never so much as seen the inside of a dentist’s office, so I didn’t really know what to expect. The reality was amazing: I went to a tiny little office a few blocks down from National Review’s palatial penthouse at Buckley Towers, where a lovely young Indian immigrant gazed into my mug and compared some enamels samples like a painter trying to decide whether your living room is actually “Westhighland white” or more of a “Restoration ivory,” and...

BEGIN TRANSCRIPT RUSH: Have you heard about the controversy over the cost of the EpiPen? I bet there's something you don't know about this. Hillary Clinton is out raising hell over the price, the skyrocketing cost of EpiPens. These are things, you shoot epinephrine into somebody that needs to a jolt, peanut allergy or some such thing, this causes an immediate fix for it. The price for these devices has skyrocketed 400% recently, and yet ABC and CBS, in talking about this, have failed to identify the pharmaceutical company involved. And there's a reason why. And NBC as well. ABC,...

Makers of the EpiPen auto-injector said they would offer a 50 percent discount after public outrage over a 500-percent price hike. Hillary Clinton was among those calling for the price reduction – and her supporters were quick to give her all the credit. EpiPen administers a quick dose of epinephrine to counter a severe, life-threatening allergic reaction known as anaphylaxis. The easy-to-use injector is made by West Virginia-based Mylan Pharmaceuticals, which bought the rights to it in 2007. Since then, the price of the EpiPen has skyrocketed, going from $100 to $600. On Thursday, Reuters seemed to give Clinton the...

The pharmaceutical company under fire for increasing the cost of its life-saving EpiPen has been criticized by Hillary Clinton — despite the fact that the manufacturer donated to the Clinton Foundation. Records available on the website of the Bill, Hillary and Chelsea Clinton Foundation reveal Mylan, the company that manufactures the EpiPen, has donated up to $250,000.

West Virginia Democrat Sen. Joe Manchin’s daughter, Mylan CEO Heather Bresch, who has come under fire for her company’s widely-slammed decision to raise the cost of the EpiPen by 461 Percent since 2007, raised her salary by a whopping 671 percent during her tenure at the pharmaceutical giant. Bresch’s annual income jumped from $2,453,456 in 2007 to $18,931,068 in 2015, coinciding with the astounding price increase on the life-saving emergency allergy shot, The Chicago Tribune reports. In addition to her astoundingly high salary, Bresch reportedly took advantage of a number of unprecedented perks, including personal use of the company’s aircraft....

CEO who gouged price of EpiPen is daughter of Democrat senator CHARLESTON, W.Va. — As a pharmaceutical company run by U.S. Sen. Joe Manchin’s daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum. The Democratic West Virginia senator’s daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens. A two-dose package cost around $94 nine years ago. The cost averaged more than six times that in May. Manchin spokesman Jonathan Kott said Wednesday the senator had no comment.

As a pharmaceutical company run by U.S. Sen. Joe Manchin's daughter faces scrutiny for hiking prices on life-saving allergy injection pens, Manchin is remaining mum. The Democratic West Virginia senator's daughter, Heather Bresch, is CEO of Mylan, which manufactures EpiPens.

Washington (CNN)The incredible increase in the cost of EpiPens, auto-injectors that can stop life-threatening emergencies caused by allergic reactions, has hit home on Capitol Hill, where one Democratic senator whose daughter has allergies has called for action and another Democratic senator's daughter is CEO of the company responsible for the price hike. Sen. Amy Klobuchar of Minnesota, a Democrat whose daughter relies on EpiPen, urged the Senate Judiciary Committee to investigate the price increase of the medication, calling it "unjustified." Meanwhile, the daughter of Sen. Joe Manchin, the Democrat of West Virginia, has a very different personal connection. His daughter...